Rare diseases
Investigational molecules
Locations
Back to Austria841 clinical trials in Vienna, Austria across 10 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis
AustriaStudy on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis
AustriaStudy comparing 177Lu-edotreotide versus everolimus in patients with inoperable progressive neuroendocrine tumors of gastroenteric or pancreatic origin
AustriaStudy on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis
AustriaStudy Comparing Sacituzumab Govitecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Treatments
AustriaStudy on the Effectiveness and Safety of Iptacopan for Adults with Atypical Hemolytic Uremic Syndrome Not Previously Treated with Complement Inhibitors
AustriaStudy of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer
AustriaStudy on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination
AustriaStudy on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis
AustriaStudy on the Effectiveness and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Children with Multiple Sclerosis
AustriaStudy on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery
AustriaStudy of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation
AustriaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for various cancer types, including pancreatic ductal adenocarcinoma, gastric cancer, and non-small cell lung cancer. Studies evaluating new therapeutic approaches for breast cancer and multiple myeloma are also underway.
Research includes evaluation of novel drug combinations and immunotherapy approaches for improved patient outcomes.
Investigations into major depression and its treatment mechanisms, including studies on dopamine synthesis and antidepressant effectiveness. Research examines innovative therapeutic approaches using ketamine and other compounds.
Focus on understanding brain activation patterns and treatment responses in psychiatric conditions.
Research on plaque psoriasis, rheumatic diseases, and Sjögren's syndrome. Studies evaluate new biological therapies and treatment approaches for chronic inflammatory conditions.
Emphasis on developing targeted therapies for improved disease management and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
